The perioperative use of oral anticoagulants during surgical procedures for carpal tunnel syndrome. A preliminary study.
Fulltext:
87781.pdf
Embargo:
until further notice
Size:
82.07Kb
Format:
PDF
Description:
Publisher’s version
Publication year
2010Source
Acta Neurochirurgica, 152, 7, (2010), pp. 1211-3ISSN
Annotation
01 juli 2010
Publication type
Article / Letter to editor
Display more detailsDisplay less details
Organization
Neurosurgery
Journal title
Acta Neurochirurgica
Volume
vol. 152
Issue
iss. 7
Page start
p. 1211
Page end
p. 3
Subject
DCN 1: Perception and Action; NCEBP 4: Quality of hospital and integrated careAbstract
BACKGROUND: To evaluate the feasibility of designing a randomized controlled study whether open carpal tunnel release (OCTR) surgery can be performed safely under systemic anticoagulant therapy using acetylsalicylacid (ASA) or acenocoumarol (ACM), this preliminary, observational study was performed. METHODS: Prospectively, during 1 year, data were collected from all patients who underwent conventional OCTR at the neurosurgical department of the Canisius Wilhelmina Hospital, Nijmegen, The Netherlands. Patients continued anticoagulant treatment perioperatively. RESULTS: A total of 364 patients were operated on, of whom 45 continued ASA and seven ACM treatment. Only one patient using ASA complained of a postoperative subcutaneous hemorrhage. In the control group without anticoagulants, none of the patients had a bleeding postoperatively. CONCLUSION: Continuation of anticoagulant treatment is safe for OCTR. The adverse effects of stopping treatment for surgery can be severe. As a result of this study, we have changed our surgery protocol for OCTR and continue anticoagulant treatment perioperatively.
This item appears in the following Collection(s)
- Academic publications [246625]
- Electronic publications [134162]
- Faculty of Medical Sciences [93367]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.